# Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

> **NCT00870727** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 33 (actual)

## Conditions studied

- Pervasive Developmental Disorder

## Interventions

- **DRUG:** Aripiprazole oral product
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT00870727
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-01-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870727, "Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00870727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*